Cyclophosphamide
- Product NDC
- 69097-517
- 11-digit product format
- 690970517
- Labeler code
- 69097
- Product ID
- 69097-517_11c7b59d-18e5-4efb-bc77-5877d9b89bb1
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Cyclophosphamide
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Cipla USA Inc.
- Application
- ANDA211608
- Marketing category
- ANDA
- Marketing start
- 2019-01-18
- Substance
- CYCLOPHOSPHAMIDE
- Active strength
- 50 mg/1
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Cyclophosphamide
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CYCLOPHOSPHAMIDE | 50 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 8N3DW7272P |
| Rxcui | 1437968, 1437969 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 69097-517-07 | Cyclophosphamide | 100 in 1 BOTTLE | CAPSULE | 100 | | 6 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 69097-517 | CYCLOPHOSPHAMIDE CAPSULE [CIPLA USA INC.] | 6 | Current NDC, Legacy NDC, 1 package rows | 20250117_0e1cb955-99c8-4fe5-89d1-399c8e52174e.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69097-517-07 | 69097051707 | 100 CAPSULE in 1 BOTTLE (69097-517-07) | 100 capsule | 2019-01-18 | 0000-00-00 | No | No | Current |